Perceptive Advisors’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.2M Buy
+462,506
New +$25.2M 0.37% 46

Other funds holding ELVN

Perceptive Advisors's ELVN Position: Q3 2026 in Review

Perceptive Advisors opened a new position in Enliven Therapeutics (ELVN) in Q3 2026: 462,506 shares worth $21.2M. The stake represents 0.37% of the portfolio and ranks #46 among its holdings.

216 funds tracked by Wall St. Rank hold ELVN as of Q3 2026.

  • Perceptive Advisors held 462,506 shares of Enliven Therapeutics worth $21.2M as of Q3 2026.
  • Enliven Therapeutics was a new Perceptive Advisors position in Q3 2026.
  • Enliven Therapeutics made up 0.37% of Perceptive Advisors's portfolio in Q3 2026, its #46 holding.
  • 216 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q3 2026.

Based on Perceptive Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.